Singapore markets closed

Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
68.20+0.49 (+0.72%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 53.20B
Enterprise value 49.90B
Trailing P/E 30.85
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.06
Price/book (mrq)6.68
Enterprise value/revenue 12.25
Enterprise value/EBITDA 25.27

Trading information

Stock price history

Beta (5Y monthly) -0.61
52-week change 315.39%
S&P500 52-week change 324.96%
52-week high 383.50
52-week low 352.73
50-day moving average 372.23
200-day moving average 370.98

Share statistics

Avg vol (3-month) 34.16M
Avg vol (10-day) 35.83M
Shares outstanding 5785.72M
Implied shares outstanding 6798.13M
Float 8327.17M
% held by insiders 160.58%
% held by institutions 116.35%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41
Forward annual dividend yield 41.48%
Trailing annual dividend rate 31.00
Trailing annual dividend yield 31.48%
5-year average dividend yield 4N/A
Payout ratio 431.89%
Dividend date 3N/A
Ex-dividend date 415 May 2024
Last split factor 21.9:1
Last split date 321 May 2021

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 42.32%
Operating margin (ttm)44.22%

Management effectiveness

Return on assets (ttm)14.25%
Return on equity (ttm)23.44%

Income statement

Revenue (ttm)4.08B
Revenue per share (ttm)5.19
Quarterly revenue growth (yoy)16.60%
Gross profit (ttm)N/A
EBITDA 1.96B
Net income avi to common (ttm)1.72B
Diluted EPS (ttm)2.19
Quarterly earnings growth (yoy)20.00%

Balance sheet

Total cash (mrq)3.3B
Total cash per share (mrq)4.2
Total debt (mrq)4.71M
Total debt/equity (mrq)0.06%
Current ratio (mrq)9.72
Book value per share (mrq)10.14

Cash flow statement

Operating cash flow (ttm)1.5B
Levered free cash flow (ttm)999.42M